Cargando…

The Association of Coagulation Factor V (Leiden) and Factor II (Prothrombin) Mutations With Stroke

BACKGROUND: Epidemiological studies indicate that over the past forty years, the stroke incidence rates has increased. Factors V and II mutations are established genetic-variant risk factors for venous thrombosis; however, their contribution to stroke is a controversial issue. OBJECTIVES: This study...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pirhoushiaran, Maryam, Ghasemi, Mohammad Reza, Hami, Javad, Zargari, Peyman, Sasan Nezhad, Payam, Azarpazhooh, Mahmood Reza, Sadr Nabavi, Ariane
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Kowsar 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4329966/ https://www.ncbi.nlm.nih.gov/pubmed/25763204 http://dx.doi.org/10.5812/ircmj.11548

Ejemplares similares

Fibronectin Regulation by Vitamin C Treatment in Kidneys of Nicotinic Mice Offspring
por: Pahang, Hasan, et al.
Publicado: (2014)

Factor V Leiden and Prothrombin 20210A Mutations among Turkish Pediatric Leukemia Patients
por: Akın, Dilara Fatma, et al.
Publicado: (2012)

Impact of prothrombin and factor V Leiden mutations on the progression of fibrosis in patients with chronic hepatitis C
por: Naguib, Mary, et al.
Publicado: (2022)

Factor V Leiden, Prothrombin and MTHFR Mutation in Patients with Preeclamsia, Intrauterine Growth Restriction and Placental Abruption
por: Livrinova, Vesna, et al.
Publicado: (2015)

Direct‐to‐consumer genetic testing for factor V Leiden and prothrombin 20210G>A: the consumer experience
por: Elson, Sarah L., et al.
Publicado: (2020)

Anticoagulation Therapy in a Patient With Heterozygous Factor V Leiden and Coexisting Homozygous Prothrombin Gene Mutations
por: Costa, Ryder L, et al.
Publicado: (2020)

Factor V Leiden G1691A and Prothrombin Gene G20210A Mutations on Pregnancy Outcome
por: Padda, Jaskamal, et al.
Publicado: (2021)

Acquired deficiency of prothrombin complex coagulation factors in major bleeding is a therapeutic indication of 4‐factor prothrombin complex concentrates
por: Wiedermann, Christian J.
Publicado: (2020)

Prothrombin gene and factor V Leiden gene polymorphism in patients with deep vein thrombosis: prevalence, diagnostic and therapeutic implications
por: Rizk, A, et al.
Publicado: (2006)

Acute Myocardial Infarction in Patients with Hereditary Thrombophilia—A Focus on Factor V Leiden and Prothrombin G20210A
por: Badescu, Minerva Codruta, et al.
Publicado: (2023)

The Combined Heterozygosity of Factor V Leiden and G20210A Prothrombin Gene Mutation in a Patient With Venous Thromboembolism
por: Machado, Marcia, et al.
Publicado: (2023)

Risk of Budd-Chiari Syndrome Associated with Factor V Leiden and G20210A Prothrombin Mutation: A Meta-Analysis
por: Zhang, Peijin, et al.
Publicado: (2014)

Diagnostic ramifications of ocular vascular occlusion as a first thrombotic event associated with factor V Leiden and prothrombin gene heterozygosity
por: Schockman, Samantha, et al.
Publicado: (2015)

Association of Factor V Leiden and Prothrombin G20210A Polymorphisms in Women with Recurrent Pregnancy Loss in Isfahan Province, Iran
por: Kardi, Mohammad Taghi, et al.
Publicado: (2018)

The Role of Factor V Leiden, Prothrombin G20210A, and MTHFR C677T Mutations in Neonatal Cerebral Sinovenous Thrombosis
por: Garrido-Barbero, Maria, et al.
Publicado: (2019)

Thrombophilic Risk of Factor V Leiden, Prothrombin G20210A, MTHFR, and Calreticulin Mutations in Essential Thrombocythemia Egyptian Patients
por: El-Ghonemy, Mohamed S., et al.
Publicado: (2020)

Pharmacogenetic typing for oral anti-coagulant response among factor V Leiden mutation carriers
por: Nahar, Risha, et al.
Publicado: (2012)

Factor V Leiden G1691A and prothrombin G20210A mutations among Palestinian patients with sickle cell disease
por: Samarah, Fekri, et al.
Publicado: (2018)

SV-IV Peptide1–16 reduces coagulant power in normal Factor V and Factor V Leiden
por: Di Micco, Biagio, et al.
Publicado: (2007)

THE FACTORS OF COAGULATION IN THE EXPERIMENTAL APLASTIC ANEMIA OF BENZOL POISONING, WITH SPECIAL REFERENCE TO THE ORIGIN OF PROTHROMBIN
por: Hurwitz, S. H., et al.
Publicado: (1915)

Association of 5-lipoxygenase activating protein gene polymorphism and stroke: A study from north east of Iran
por: Erfani, Marjan, et al.
Publicado: (2019)

Factor-V Leiden G1691A and prothrombin G20210A polymorphisms in Sudanese women with preeclampsia, a case -control study
por: Ahmed, Nadir A., et al.
Publicado: (2019)

Examination of in Factor V Leiden and Prothrombin II Thrombophilic Mutations in Czech Young Women Using ddPCR—Prevalence and Cost–Benefit Analysis
por: Riedlova, Petra, et al.
Publicado: (2021)

Factor V Leiden and Inflammation
por: Perez-Pujol, Silvia, et al.
Publicado: (2012)

Role of prothrombin complex concentrate in perioperative coagulation therapy
por: Tanaka, Kenichi A, et al.
Publicado: (2014)

Blood coagulation factor Va's key interactive residues and regions for prothrombinase assembly and prothrombin binding
por: Schreuder, Mark, et al.
Publicado: (2019)

Prothrombin Time and Coagulation Factor IX as Hemostatic Risk Markers for Legg– Calvé–Perthes Disease
por: Hernández-Zamora, Edgar, et al.
Publicado: (2023)

The Association of Factor V Leiden and Prothrombin Gene Mutation and Placenta-Mediated Pregnancy Complications: A Systematic Review and Meta-analysis of Prospective Cohort Studies
por: Rodger, Marc A., et al.
Publicado: (2010)

Large‐scale screening for factor V Leiden (G1691A), prothrombin (G20210A), and MTHFR (C677T) mutations in Greek population
por: Raptopoulou, Alkistis, et al.
Publicado: (2022)

Association between Polymorphism eNOS4, tPA, Factor V Leiden, Prothrombin, and Methylenetetrahydrofolate Reductase and the Occurrence of Legg–Calvé–Perthes Disease
por: Matuszewska, Anna, et al.
Publicado: (2023)

A case of pulmonary thromboembolism due to coagulation factor V Leiden in Japan ~ usefulness of next generation sequencing~
por: Sueta, Daisuke, et al.
Publicado: (2017)

Evaluation of a Genetic Test for Diagnose of Primary Hypolactasia in Northeast of Iran (Khorasan)
por: Alizadeh, Maryam, et al.
Publicado: (2012)

MTHFR C677T, Prothrombin G20210A, and Factor V Leiden (G1691A) Polymorphism and Beta-Thalassemia Risk: A Meta-Analysis
por: Nigam, Nitu, et al.
Publicado: (2020)

Complications in Diagnosis of Susceptible Cases of Fragile X Syndrome
por: JAFARZADEH ESFEHANI, Reza, et al.
Publicado: (2018)

Evaluation of COVID-19 Trend in Iran; Population Response to the Recent Pandemic Overtime
por: Esfehani, Reza Jafarzadeh, et al.
Publicado: (2022)

Right Ventricular Thrombus in a 36-Year-Old Man with Factor V Leiden
por: Hajsadeghi, Shokoufeh, et al.
Publicado: (2015)

STUDIES ON BLOOD COAGULATION : I. THE RÔLE OF PROTHROMBIN AND OF PLATELETS IN THE FORMATION OF THROMBIN
por: Eagle, Harry
Publicado: (1935)

Theoretical Modeling of Coagulation Management With Therapeutic Plasma or Prothrombin Complex Concentrate
por: Schöchl, Herbert, et al.
Publicado: (2017)

Influence of prothrombin complex concentrates on plasma coagulation in critically ill patients
por: Staudinger, T., et al.
Publicado: (1999)

Non-collagenous extracellular matrix protein dermatopontin may play a role as another component of transforming growth factor-β signaling pathway in colon carcinogenesis
por: Sadr-Nabavi, Ariane, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_fs150eb2krsm5nl8bd0jav3que